| CTRI Number |
CTRI/2020/08/027031 [Registered on: 07/08/2020] Trial Registered Prospectively |
| Last Modified On: |
06/08/2020 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia Preventive |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
comparison of two drugs for prevention of post operative nausea and vomiting |
|
Scientific Title of Study
|
To compare the efficacy of palonosetron dexamethasone combination with palonosetron and dexamethasone alone for prevention of post operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Anita Kumari |
| Designation |
Professor |
| Affiliation |
Sri Guru Ram Das Institute of Medical Sciences and Research |
| Address |
Department of Anaesthesia,
SGRDIMSAR,
Amritsar Department of Anaesthesia,
SGRDIMSAR,
Amritsar Amritsar PUNJAB 143501 India |
| Phone |
9815632909 |
| Fax |
|
| Email |
kumarianitadr1@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Anita Kumari |
| Designation |
Professor |
| Affiliation |
SGRDIMSAR |
| Address |
Department of Anaesthesia,
SGRDIMSAR,
Amritsar Department of Anaesthesia,
SGRDIMSAR,
Amritsar
PUNJAB 143501 India |
| Phone |
9815632909 |
| Fax |
|
| Email |
kumarianitadr1@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Chanpreet Kaur |
| Designation |
Junior Resident |
| Affiliation |
SGRDIMSAR |
| Address |
Department of Anaesthesia,
SGRDIMSAR,
Amritsar Department of Anaesthesia,
SGRDIMSAR,
Amritsar Amritsar PUNJAB 143501 India |
| Phone |
9646457241 |
| Fax |
|
| Email |
nchanpreet@gmail.com |
|
|
Source of Monetary or Material Support
|
| Department of Anaesthesia, SGRDIMSAR, Amritsar |
|
|
Primary Sponsor
|
| Name |
NA |
| Address |
NA |
| Type of Sponsor |
Other [] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Anita Kumari |
SGRDIMSAR |
Operation Theater
SGRDIMSAR Amritsar PUNJAB |
9815632909
kumarianitadr1@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| SGRD ethical committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K802||Calculus of gallbladder without cholecystitis, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
inj.palonosetron and inj. dexamethasone |
Group A will receive 0.075 mg inj. palonosetron along with 8mg of inj. dexamethasone
Group B will receive 0.075 mg of inj. palonosetron
Group C will receive 8 mg of inj. dexamethasone
|
| Comparator Agent |
palonosetron and dexamethasone |
To compare the efficacy of palonosetron, dexamethasone and their combination for prevention of post operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Patients belonging to ASA grade 1 and 2.
Patients posted for elective laparoscopic cholecystectomies under general anaesthesia.
|
|
| ExclusionCriteria |
| Details |
Patient refusal.
Patients with known hypersensitivity or contraindications to study drugs.
Patients posted for emergency surgery.
Patients with history of nausea, vomiting or retching in 24 hours before anaesthesia.
5. Patients receiving antiemetic therapy in 24 hours before surgery.
6. Patients with history of motion sickness.
7. Pregnant female.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
postoperative nausea and vomiting in patients undergoing elective laparoscopic cholecystectomies under general anaesthesia.
|
one hourly for the first four hours then at 8, 12, 18,24,30,36,42,48 hours |
|
|
Secondary Outcome
|
|
|
Target Sample Size
|
Total Sample Size="75" Sample Size from India="75"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
09/08/2020 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
NA |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Post operative nausea and vomiting is
highly distressing and unpleasant symptom. Inj. Palonosetron and inj. dexamethasone
are effective antiemetics with minimal side effect profile. This study compares
the efficacy of inj.
palonosetron or dexamethasone alone and their
combination (inj.
palonosetron+ inj. dexamethasone) for
prevention of post operative nausea and vomiting after laparoscopic
cholecystectomy. The study will be done on 75 adult
patients of ASA I and ASA II aged 18-60 years. They will be allocated into
three groups of 25 each and will receive either of three treatment regimens
.075mg palonosetron+8mg dexamethasone, 0.075 mg inj. palonosetron
and 8mg inj.
dexamethasone intravenously in group A, B and C
respectively. Nausea, retching, vomiting, pain will be recorded 1 hourly for 4
hours and then 4 hourly till next 12 hours and 6 hourly thereafter till 48
hours. |